Alaunos Therapeutics Inc
Change company Symbol lookup
Select an option...
TCRT Alaunos Therapeutics Inc
VLO Valero Energy Corp
BBLN+ Babylon Holdings Equity Warrants 21st Oct 2026 *W EXP 10/21/2026
NEGG Newegg Commerce Inc
RCLF Rosecliff Acquisition Corp I
SSYS Stratasys Ltd
GRN iPath? Series B Carbon ETN
RCKTF Rock Tech Lithium Inc
SOND Sonder Holdings Inc

Health Care : Biotechnology | Small Cap Value
Company profile

Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. The Company is engaged in developing adoptive TCR engineered T-cell therapies (TCR-T), designed to treat multiple solid tumor types in large cancer patient populations. The Company is leveraging its cancer mutation hotspot TCR library and its non-viral Sleeping Beauty genetic engineering technology to design and manufacture patient-specific cell therapies that target neoantigens arising from common tumor-related mutations in key oncogenic genes, including KRAS, TP53 and EGFR. Its TCR library consists of ten TCRs targeting six solid tumor indications, including non-small cell lung, colorectal, endometrial, pancreatic, ovarian and bile duct cancers. Using its human neoantigen T cell Receptor (hunTR) discovery engine, it analyzes thousands of single T cells simultaneously using bioinformatics and next generation sequencing. Its pipeline includes Library TCR-T cell therapy and mbIL-15 TCR-T cell therapy.

Day's Change
-0.02 (-0.93%)
B/A Size
Day's High
Day's Low

Today's volume of 2,570,829 shares is on pace to be much lighter than TCRT's 10-day average volume of 10,567,364 shares.

  • Prev Close
  • Today's Open
  • Day's Range
  • Avg Vol (10-day)
  • Last (time)
    12:28p ET 09/27/22
  • Last (size)
  • 52-Wk Range
    0.4053 - 4.01
  • (04/28/22 - 09/09/22)
  • 136.8%
  • Market Cap
  • Shares Outstanding
  • -0.25
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.3
  • 40.14
  • (% of float 08/31/22)

Latest News

September 27, 2022
9:31 am ET
PR Newswire
September 23, 2022
9:31 am ET
PR Newswire
September 22, 2022
9:31 am ET
PR Newswire
September 21, 2022
8:30 am ET
Globe Newswire
September 14, 2022
9:31 am ET
PR Newswire
September 07, 2022
9:31 am ET
PR Newswire
8:30 am ET
Globe Newswire
September 06, 2022
8:00 am ET
Globe Newswire
August 25, 2022
9:34 am ET
PR Newswire
August 24, 2022
3:00 pm ET
Globe Newswire
August 15, 2022
7:00 am ET
Globe Newswire
August 08, 2022
8:50 am ET
Globe Newswire
August 04, 2022
5:00 pm ET
Globe Newswire
July 06, 2022
9:45 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.